Renal Manifestation in Paroxysmal Nocturnal Hemoglobinuria: A Case Report from Northeast India
Authors/Creators
- 1. International Journal of Medical Science and Advanced Clinical Research (IJMACR)
Description
Abstract
Paroxysmal Nocturnal Hemoglobinuria (PNH) is an infrequent, acquired hematological disorder characterized by intravascular hemolysis and a spectrum of complications, including renal impairment. A 25-year-old male with established PNH presented with abdominal discomfort, emesis, dark-hued urine, and diminished urine output following substantial alcohol consumption. Laboratory investigations revealed severe anemia accompanied by a pronounced elevation in serum creatinine levels. Despite the implementation of supportive care, renal function deteriorated, necessitating hemodialysis. Renal biopsy demonstrated acute tubular injury with significant hemosiderin deposition. Following treatment with corticosteroids, dialysis, and blood transfusions, renal function was fully restored. This case underscores the peril of severe acute kidney injury in patients with PNH and accentuates the importance of renal biopsy in ambiguous clinical scenarios. It also prompts contemplation regarding the frequency with which acute kidney injury is overlooked in this patient population.
Files
ANGELIA.pdf
Files
(979.4 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:14bb06c28fb7842258654cf316b1daa8
|
979.4 kB | Preview Download |
Additional details
Software
- Repository URL
- https://www.ijmacr.com/issue/archive_issue/64
References
- 1. Bessler M, Hiken J. The pathophysiology of disease in patients with paroxysmal nocturnal hemoglobinuria. Hematology / the Education Program of the American Society of Hematology American Society of Hematology Education Program. 2008; 2. Kokoris SI, Gavriilaki E, Miari A, Travlou Α, Kyriakou E, Anagnostopoulos A, et al. Renal involvement in paroxysmal nocturnal hemoglobinuria: an update on clinical features, pathophysiology and treatment. Hematology. 2018;23(8). 3. Kelly R, Richards S, Hillmen P, Hill A. The pathophysiology of paroxysmal nocturnal hemoglobinuria and treatment with eculizumab. Vol. 5, Therapeutics and Clinical Risk Management. 2009. 4. Hillmen P, Young NS, Schubert J, Brodsky RA, Socié G, Muus P, et al. The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria. New England Journal of Medicine. 2006;355(12). 5. Risitano AM, Marotta S, Ricci P, Marano L, Frieri C, Cacace F, et al. Anti-complement Treatment for Paroxysmal Nocturnal Hemoglobinuria: Time for proximal complement inhibition? A position paper from the SAAWP of the EBMT. Vol. 10, Frontiers in Immunology. 2019. 6. Bodó I, Amine I, Boban A, Bumbea H, Kulagin A, Lukina E, et al. Complement Inhibition in Paroxysmal Nocturnal Hemoglobinuria (PNH): A Systematic Review and Expert Opinion from Central Europe on Special Patient Populations. Adv Ther. 2023;40(6). 7. Chen SC, Hung CC, Hsu CP, Chiu YW, Liu YC, Tsai JC, et al. Recurrent acute renal failure in a patient with aplastic anemia-paroxysmal nocturnal hemoglobinuria syndrome: A case report. Kaohsiung Journal of Medical Sciences. 2007;23(11). 8. Patel PB, Hota J. A Case of Paroxysmal Nocturnal Hemoglobinuria with Renal Hemosiderosis. Apollo Medicine. 2019;16(3). 9. Ram R, Adiraju KP, Gudithi S, Dakshinamurty K V. Renal manifestations in paroxysmal nocturnal hemoglobinuria. Indian J Nephrol. 2017;27(4). 10. Choi H, Yim H, Lee MJ. Hemosiderin induced acute kidney injury requiring hemodialysis in patients with paroxysmal nocturnal hemoglobinuria A case report. Medicine (United States). 2023;102(40). 11. Puri V, Gandhi A, Sharma S. Renal biopsy in paroxysmal nocturnal hemoglobinuria: An insight into the spectrum of morphologic changes. Indian J Nephrol. 2017;27(4). 12. Satish S, Rajesh R, Kurian G, Seethalekshmi N V, Unni M, Unni VN. Recurrent acute renal failure. Indian J Nephrol [Internet]. 2010;20(4):217–9. Available from: https://doi.org/10.4103/0971-4065.73444 13. Mauro E, Gherlinzoni F. Efficacy and safety of Eculizumab in Paroxysmal Nocturnal Hemoglobinuria (PNH) after 15 years steroids treatment: a case report description. International Journal of Medical Reviews and Case Reports. 2019;(0). 14. Ranade RS, Desai A, Mayya MH, Patil ST, Rani H, Revanasiddappa M. Clinicopathological study of pigment induced nephropathy; a retrospective study. J Nephropathol. 2024;13(2).